ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Events

Esperion Therapeutics, Inc. (ESPR)

NASDAQ

$3.42

$+0.25

(+8.02%)

Esperion Therapeutics, Inc. (ESPR) Live Price Chart

Page last updated: 2026-02-06 18:33:00

Key Market Data

Market Cap	$816.40M
Open	$3.25
High	$245.28
Low	$0.69
Previous Close	$3.18
Price Change	$+0.25
Percentage Change	+8.02%
Volume	3M

Esperion Therapeutics, Inc. (ESPR) Stock Price Today

Esperion Therapeutics, Inc. (ESPR) is currently trading at $3.42 as of 2026-02-06 18:33:00, reflecting a +8.02% move ($+0.25) from the previous close.

In the short term, the stock has returned -1,265.98% over the past four weeks. Over the last 12 months, Esperion Therapeutics, Inc. has recorded a +84.59% price change, indicating a strong performance relative to the broader market.

Esperion Therapeutics, Inc. (ESPR) 7-Day Stock Price Changes

Over the past seven days, Esperion Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $3.39 to the latest recorded price of $3.42, reflecting an intraday change of +8.02%. Daily movements highlight shifts in trading volume (3,077,766), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, ESPR has delivered a -1,265.98% return over the past month and a +84.59% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Esperion Therapeutics, Inc. (ESPR)

You can buy and trade ESPR on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for ESPR and Execute Your Trade

Open the trading page, enter ESPR in the search bar, select the amount of ESPR you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Esperion Therapeutics, Inc. (ESPR)?

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Esperion Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	304
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.esperion.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Esperion Therapeutics, Inc.?

The latest trading price for Esperion Therapeutics, Inc. (Common Stock) is $ 3.42, compared with a previous closing price of $ 3.18. That means the stock has moved +8.02% so far today. Intraday price updates and recent trading activity for ESPR can be tracked on the live chart and quote section on this page.

2.Is Esperion Therapeutics, Inc. stock going up or down?

Looking at recent performances, ESPR has returned -1,265.98% over the past month, +85.09% over the last six months and +84.59% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Esperion Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does ESPR currently sit relative to its 52-week high and low?

In the most recent 52-week period, Esperion Therapeutics, Inc. has traded between a low of $ 0.69 and a high of $ 4.18. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether ESPR is currently nearer the top or the bottom of its one-year trading band.

4.How is Esperion Therapeutics, Inc. classified by sector and industry?

Esperion Therapeutics, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector, within the PHARMACEUTICAL PREPARATIONS industry group and the PHARMACEUTICAL PREPARATIONS industry. In practice, this means Esperion Therapeutics, Inc. is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing ESPR's sector and industry classification helps when building diversified portfolios, comparing Esperion Therapeutics, Inc. with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the PHARMACEUTICAL PREPARATIONS sector and PHARMACEUTICAL PREPARATIONS industry.

5.Where is Esperion Therapeutics, Inc. listed and how large is it by market value?

Esperion Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 816.40M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Esperion Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does ESPR's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.44 summarises how much profit Esperion Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Esperion Therapeutics, Inc.'s financial performance over time?

To follow Esperion Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how ESPR is performing and how the market is responding.

8.When is Esperion Therapeutics, Inc. expected to report earnings?

Esperion Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for ESPR, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Esperion Therapeutics, Inc.'s earnings reports?

Esperion Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether ESPR is meeting, beating or missing expectations.

10.How can I stay informed about Esperion Therapeutics, Inc.'s results and guidance?

You can stay up to date on Esperion Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for ESPR on this page helps you see how new information is being reflected in the stock.

11.Does Esperion Therapeutics, Inc. pay a regular cash dividend to its shareholders?

Esperion Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor ESPR's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for ESPR?

Based on the latest earnings data, ESPR has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Esperion Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Esperion Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Esperion Therapeutics, Inc.?

Esperion Therapeutics, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is ESPR valued in terms of P/E ratio and EPS?

Esperion Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.44. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Esperion Therapeutics, Inc.'s earnings. Comparing ESPR's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Esperion Therapeutics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Arcosa, Inc.

ACA

Amphenol Corporation

APH

Vaalco Energy, Inc.

EGY

Pediatrix Medical Group, Inc.

MAXIMUS, Inc.

MMS

Top Gainers

Browse today's leading gainers in the US stock market

Bio Green Med Solution, Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

ESPR-to-USD Calculator

Amount

ESPR

USD

1 ESPR = 3.415 USD